Clinical Trial Update: High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating high-dose testosterone for metastatic prostate cancer with ATM, CDK12, or CHEK2 alterations; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: RECRUITING